PIM
DMTX

Partner Investment Management’s Dimension Therapeutics, Inc DMTX Stock Holding History

Partner Investment Management’s Portfolio DMTX Stock Details DMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-9,885
Closed -$79K – 120
2016
Q3 		$79K Sell
9,885
-4,876
-33% -$35.3K 0.12% 83
2016
Q2 		$89K Sell
14,761
-1,539
-9% -$11.7K 0.15% 73
2016
Q1 		$125K Sell
16,300
-2,326
-12% -$18.3K 0.2% 74
2015
Q4 		$196K Buy
+18,626
New +$236K 0.32% 56

Other funds holding DMTX

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return

Partner Investment Management's DMTX Position: Q4 2016 in Review

Partner Investment Management sold out of Dimension Therapeutics, Inc (DMTX) in Q4 2016, closing a stake of 9,885 shares — an estimated $79K sold.

Partner Investment Management first reported a position in DMTX in Q4 2015 and held it in 4 quarters. The position peaked at $196K in Q4 2015. 55 funds tracked by Wall St. Rank hold DMTX as of Q4 2016.

  • Partner Investment Management reported no remaining Dimension Therapeutics, Inc position as of Q4 2016 after selling out during the quarter.
  • Partner Investment Management sold 9,885 Dimension Therapeutics, Inc shares in Q4 2016, an estimated $79K.
  • Partner Investment Management first reported a position in Dimension Therapeutics, Inc in Q4 2015 and held it in 4 quarters.
  • Partner Investment Management's Dimension Therapeutics, Inc position peaked at $196K in Q4 2015.
  • 55 funds tracked by Wall St. Rank held Dimension Therapeutics, Inc as of Q4 2016.

Based on Partner Investment Management's 13F filing for Q4 2016, filed 14 Feb 2017.